Early Mobilization After a Large Middle Cerebral Artery Infarct
A 64-year-old man is admitted with a left middle cerebral artery infarct. On day 2, NIHSS is 14, with dense right hemiplegia, mild neglect, and no hemorrhagic transformation on CT; infarct volume is approximately 95 mL. He has atrial fibrillation and was taking apixaban, last dose 36 hours ago. Blood pressure is 176/94 mmHg on labetalol as needed; he is afebrile. Physical therapy requests approval for a 60-minute session including treadmill gait training at 70–80% of heart rate reserve and repetitive sit-to-stand. He is motivated and wants to “get moving.”
1. Do you approve the requested 60-minute high-intensity session on day 2? Justify your answer.
Read the worked answer
No, not as requested. On day 2 after a roughly 95 mL MCA infarct, high-dose, high-intensity mobilization has not been shown to improve outcomes, and in the AVERT trial very early, higher-dose mobilization was associated with worse functional outcomes, particularly in patients with larger infarcts and more severe deficits. His NIHSS of 14, neglect, and large infarct place him at risk for hemorrhagic transformation and hemodynamic instability, and treadmill training at 70–80% of heart rate reserve is disproportionate to his current capacity.
Approve a low-intensity, short-duration session instead: bed mobility, sitting balance, active-assisted range of motion, and assisted standing for 10–15 minutes, with vital-sign monitoring and rest breaks. Reassess daily and progress intensity as he stabilizes.
2. What blood pressure threshold would you use before and during therapy, and how would you manage an asymptomatic reading of 182/100 mmHg?
Read the worked answer
For an ischemic stroke not treated with thrombolysis, permissive hypertension is typical, and pressures up to about 220/120 mmHg are not automatically treated. An asymptomatic 182/100 mmHg before therapy is not by itself a reason to cancel rehabilitation, but it should be rechecked after 5–10 minutes of rest, and reversible triggers (pain, full bladder, anxiety, constipation) should be addressed.
If the reading persists and he remains asymptomatic, proceed with low-intensity activity and monitor. If he develops headache, chest pain, or a neurologic change, hold therapy and treat. Avoid rapid, steep blood-pressure reduction, which can worsen penumbral perfusion.
3. When would you restart anticoagulation, and how does that affect rehabilitation scheduling?
Read the worked answer
Restarting apixaban requires balancing stroke recurrence against hemorrhagic transformation. With a large infarct (approximately 95 mL), guidelines generally support delaying anticoagulation for roughly 4–14 days rather than restarting immediately; the exact timing should be decided with neurology and cardiology, incorporating his CHA2DS2-VASc score, renal function, and repeat imaging.
For rehabilitation, this means maintaining fall precautions and close neurologic monitoring during the higher-risk window, and coordinating mobilization intensity with the anticipated anticoagulation start rather than assuming full activity is safe.